UK markets open in 6 hours 2 minutes
NIKKEI 225
38,109.73 -164.32 (-0.43%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.19 +0.19 (+0.24%) GOLD FUTURES
2,334.90 +23.90 (+1.03%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,976.72 -2,026.04 (-4.22%)
Tekla Life Sciences Investors (HQL)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 357.74M |
| Enterprise value | N/A |
| Trailing P/E | 16.56 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 15.73 |
| Price/book (mrq) | 0.89 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.72 |
| 52-week change 3 | -5.76% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 14.37 |
| 52-week low 3 | 11.34 |
| 50-day moving average 3 | 13.43 |
| 200-day moving average 3 | 13.07 |
Share statistics
| Avg vol (3-month) 3 | 99.63k |
| Avg vol (10-day) 3 | 98.91k |
| Shares outstanding 5 | 27.35M |
| Implied shares outstanding 6 | 27.35M |
| Float 8 | N/A |
| % held by insiders 1 | 0.01% |
| % held by institutions 1 | 35.79% |
| Shares short (15 Apr 2024) 4 | 19.09k |
| Short ratio (15 Apr 2024) 4 | 0.23 |
| Short % of float (15 Apr 2024) 4 | N/A |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.07% |
| Shares short (prior month 15 Mar 2024) 4 | 29.43k |
Dividends & splits
| Forward annual dividend rate 4 | 1.33 |
| Forward annual dividend yield 4 | 10.17% |
| Trailing annual dividend rate 3 | 1.30 |
| Trailing annual dividend yield 3 | 9.94% |
| 5-year average dividend yield 4 | 9.13 |
| Payout ratio 4 | 162.03% |
| Dividend date 3 | 31 Dec 2018 |
| Ex-dividend date 4 | 21 Feb 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Sept 2022 |
| Most-recent quarter (mrq) | 31 Mar 2023 |
Profitability
| Profit margin | 156.45% |
| Operating margin (ttm) | -48.76% |
Management effectiveness
| Return on assets (ttm) | -0.32% |
| Return on equity (ttm) | 1.28% |
Income statement
| Revenue (ttm) | 3.51M |
| Revenue per share (ttm) | 0.13 |
| Quarterly revenue growth (yoy) | 34.40% |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | 5.5M |
| Diluted EPS (ttm) | 0.79 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 822 |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 9.33M |
| Total debt/equity (mrq) | 2.21% |
| Current ratio (mrq) | 0.27 |
| Book value per share (mrq) | 16.12 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.